Form 4 filed by Lappe Mark
Lappe Mark filed this Form 4 on INBX (Inhibrx Biosciences, Inc.) with 6 transaction rows and 1 holding row, accepted by EDGAR 2026-10-14 22:58:14 UTC.
- Accession
- 0001366074-26-000006
- Filer
- CIK 1366074
- Filed
- 2026-10-14
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: INBX · Inhibrx Biosciences, Inc. (CIK 2007919)
- Lappe Mark director, officer (Chief Executive Officer)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-10-14 | P bought | +2,470 | $84.0707 | 743,018 | I By the Lappe Family Trust |
| Common Stock | 2026-10-14 | P bought | +2,470 | $84.9992 | 745,488 | I By the Lappe Family Trust |
| Common Stock | 2026-10-14 | P bought | +100 | $85.76 | 745,588 | I By the Lappe Family Trust |
| Common Stock | 2026-10-14 | P bought | +2,449 | $84.0707 | 167,449 | I By Lappe Descendants' Trust |
| Common Stock | 2026-10-14 | P bought | +2,451 | $84.9992 | 169,900 | I By Lappe Descendants' Trust |
| Common Stock | 2026-10-14 | P bought | +100 | $85.76 | 170,000 | I By Lappe Descendants' Trust |
| Common Stock holding | 54,865 | I The Mark Paul Lappe Roth IRA |